The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…
The COVID-19 pandemic forced Congress and the Centers for Medicare & Medicaid Services (CMS) to…
Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…
12/01/24: Research Grant Cycle
Learn more
04/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to give you educational programming that encompasses your full scope of practice. Join us for the new Explorers Course 2025: Surgical & Medical Management of Airway Disease in Otolaryngology. Learn More
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access Feb 27 – May 30, 2025
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Learn More and Register
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
Are you missing rare eosinophilic disease diagnoses? Join an expert multidisciplinary panel for a podcast…
Join Drs. Puchalski, Baker and Wilson as they discuss the value of AAOA Membership. https://youtu.be/ZMhleLO-bsM…
March is such an optimistic month. (Although some may wonder this year with the extension of…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) proposed rule for CY 2022. This rule updates payment policies and payment rates for Part B services furnished under the MPFS, as…
The COVID-19 pandemic forced Congress and the Centers for Medicare & Medicaid Services (CMS) to quickly implement flexibilities to allow providers to deliver care virtually. Now many providers and patients are eager to retain access to virtual care once the…
July 2021 marks an almost 18 month journey through COVID. We have witnessed and personally experienced the loss of human lives due to the coronavirus. We have experienced significant shifts in workload and scope of practice and have felt the…
As the challenges of the pandemic change, Project N95 continues to evolve to meet community needs. As our valued partner, AAOA members have access to their pricing and access to necessary medical supplies. Project N95 continues to negotiate lower costs…
Those interested can still register and stream a video of the webcast at the link below: https://www.workcast.com/register?cpak=2535926321003375 The 2021 update of ICAR: Rhinosinusitis has been recently published in the International Forum of Allergy and Rhinology and many are asking “What…
AAOA's "Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin. The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases. Biologic…
By Christine DeMason, MD An otolaryngologist is a physician who takes care of diseases of the ears, nose, mouth and neck. Most people know otolaryngologist as an ENT or Ears, Nose and Throat doctor. Otolaryngologist take care of both children…
By Anna Butrymowicz, MD Allergy Immunotherapy (AIT) is an option for patients with allergic rhinitis (AR), allergic asthma and atopic dermatitis. In the United States, AIT is offered in two forms, subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) via tablet…
Have novel research tied to allergy, inflammatory disease in ENT, comprehensive management of allergy and inflammatory disease, or another aspect impacting ENT patient care? AAOA is currently soliciting research abstracts for consideration for its Virtual 2021 Annual Meeting. All 2021…
By Beth Wang / April 15, 2021 at 11:57 AM The House on Wednesday (April 14) passed a bipartisan bill that will require food makers declare sesame as an allergen on their food labels. The bill, which cleared the Senate in March,…